Top Markets
Coin of the day
Rua Bioscience Limited Rua Bioscience Limited

Rua Bioscience Limited

RUA
Rank in Stocks #34589
Rua Bioscience Limited, a company founded in 2016 and headquartered in... Rua Bioscience Limited, a company founded in 2016 and headquartered in Gisborne, New Zealand, is dedicated to the investigation, refinement, and production of medicinal products for both the New Zealand market and international distribution. Their offerings primarily include pharmaceuticals developed from cannabinoids. The firm officially changed its name to Rua Bioscience Limited in October 2019, having previously been known as Hikurangi Cannabis Company Limited.
Share Price
$0.01987802
Last synced: 2026-08-14
Market Cap
$5.28M
Change (1 day)
0.00%
Change (1 year)
-23.75%
Country
NZ
Trade Rua Bioscience Limited (RUA)

Category

P/E ratio for Rua Bioscience Limited (RUA)
P/E ratio as of 2026 TTM: 0
According to Rua Bioscience Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Rua Bioscience Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.